What's Happening?
South Africa is intensifying its efforts to control the spread of foot-and-mouth disease (FMD) with the recent delivery of 1.5 million doses of the Dollvet vaccine by Dunevax Biotech to Onderstepoort Biological Products (OBP). The vaccine, which targets
the SAT1, SAT2, and SAT3 serotypes of FMD, is part of a national campaign to enhance biosecurity measures. Despite the successful delivery, concerns have been raised about traceability and equipment shortages during the vaccination process. A digital tool, the Dunevax Vaccination Surveillance App, has been introduced to improve traceability and reporting. The campaign has faced challenges, including logistical issues and questions about payment for the vaccines, which were delivered based on verbal assurances from government officials.
Why It's Important?
The collaboration between the South African government and Dunevax Biotech is crucial in addressing the FMD outbreak, which poses significant risks to the livestock industry. Effective vaccination and traceability are essential to prevent the spread of the disease, which can have severe economic impacts on farmers and the agricultural sector. The introduction of a digital monitoring tool aims to enhance the efficiency and reliability of the vaccination campaign. The situation underscores the importance of public-private partnerships in managing animal health crises and highlights the need for robust biosecurity measures to protect the livestock industry.
What's Next?
The South African government and Dunevax Biotech are expected to continue their collaboration to ensure a steady supply of vaccines and improve the vaccination process. The final laboratory report from The Pirbright Institute on the virus match for the Dollvet vaccine is anticipated soon, which could further bolster confidence in the vaccine's effectiveness. Ongoing efforts to address logistical challenges and improve traceability will be critical in controlling the FMD outbreak and preventing future occurrences.
